- Report
- March 2024
- 188 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- February 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- March 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,448GBP
- Report
- November 2021
- 135 Pages
Global
From €5752EUR$5,950USD£4,944GBP
- Report
- January 2024
- 84 Pages
Global
From €3500EUR$3,878USD£3,114GBP
The Buccal Drug Delivery market is a subset of Transdermal and Transmucosal Drug Delivery, which refers to the administration of drugs through the skin or mucous membranes. Buccal Drug Delivery involves the administration of drugs through the buccal mucosa, which is the mucous membrane lining the inside of the cheeks. This method of drug delivery is advantageous because it is non-invasive, has a rapid onset of action, and is suitable for both local and systemic drug delivery. It is also advantageous for drugs that are not suitable for other routes of administration, such as those that are rapidly metabolized in the gastrointestinal tract.
Some companies in the Buccal Drug Delivery market include 3M Drug Delivery Systems, Aquestive Therapeutics, Inc., and Zosano Pharma Corporation. Show Less Read more
